Nomos' Peacock IMRT:
This article was originally published in Clinica
North American Scientific's radiation oncology division, Nomos, has received approval in China to sell its flagship intensity modulated radiation therapy (IMRT) product for treating various cancers. The Peacock system consists of the firm's Corvus treatment planning software and its MIMiC multi-leaf collimator; sales of the equiptment could begin by the end of this month. Nomos is also in the process of registering in China its BAT family of products for image-guided radiation therapy, as well as Prospera I-125 brachytherapy seeds for treating prostate cancer.
You may also be interested in...
Butterfly Network chose SPAC route with Longview Acquisition Corp. to scale its business and expand into the home market in 2021.
Regulatory review resource-intensive cell and gene therapy licensing applications are rolling toward US FDA along expedited pathways, while complete response letters and missed goal dates start to stack up under pandemic inspection constraints.
With Warp Speed Decisions Already Made, Transitioning To Biden Admin Should Be No Trouble, Slaoui Says
As vaccines near availability, Moncef Slaoui says his full-time role at OWS may be ending. He has not met with the Biden Transition team, but notes that other Warp Speed officials have.